中西医结合学报
中西醫結閤學報
중서의결합학보
JOURNAL OF CHINESE INTEGRATIVE MDEICINE
2012年
3期
256-263
,共8页
韩尽斌%花永强%陈联誉%刘鲁明
韓儘斌%花永彊%陳聯譽%劉魯明
한진빈%화영강%진련예%류로명
胰腺肿瘤%肿瘤干细胞%Smoothened%猬蛋白质类%信号传导%植物,药用%综述
胰腺腫瘤%腫瘤榦細胞%Smoothened%猬蛋白質類%信號傳導%植物,藥用%綜述
이선종류%종류간세포%Smoothened%위단백질류%신호전도%식물,약용%종술
pancreatic neoplasms%neoplastic stem cells%smoothened%hedgehog proteins%signal transduction%plants,medicinal%review
跨膜蛋白Smoothened(SMO)是音猬因子(sonic hedgehog homology,SHH)信号转导通路的主要成员,在SHH通信过程里发挥桥梁作用.在多种肿瘤组织中均可以检测到SHH的异常表达,胰腺癌干细胞SHH信号的表达明显高于普通胰腺癌细胞.SHH信号与肿瘤干细胞的自我复制,肿瘤血管和基质形成密切相关.使用以环巴胺、GDC-0449等SMO拮抗剂可以抑制SHH信号的异常转导,有效阻止肿瘤的生长和转移.目前已有多种SMO拮抗剂作为抗肿瘤药物进入Ⅰ期或Ⅱ期临床试验,已经有以SMO拮抗剂治疗胰腺癌的Ⅰ期临床试验.作为经典的SMO拮抗剂,环巴胺是从传统药用植物中提取出来的生物碱,这可能为中医药研究者提供思路,从中药中研发更加有效的SMO拮抗剂.
跨膜蛋白Smoothened(SMO)是音猬因子(sonic hedgehog homology,SHH)信號轉導通路的主要成員,在SHH通信過程裏髮揮橋樑作用.在多種腫瘤組織中均可以檢測到SHH的異常錶達,胰腺癌榦細胞SHH信號的錶達明顯高于普通胰腺癌細胞.SHH信號與腫瘤榦細胞的自我複製,腫瘤血管和基質形成密切相關.使用以環巴胺、GDC-0449等SMO拮抗劑可以抑製SHH信號的異常轉導,有效阻止腫瘤的生長和轉移.目前已有多種SMO拮抗劑作為抗腫瘤藥物進入Ⅰ期或Ⅱ期臨床試驗,已經有以SMO拮抗劑治療胰腺癌的Ⅰ期臨床試驗.作為經典的SMO拮抗劑,環巴胺是從傳統藥用植物中提取齣來的生物堿,這可能為中醫藥研究者提供思路,從中藥中研髮更加有效的SMO拮抗劑.
과막단백Smoothened(SMO)시음위인자(sonic hedgehog homology,SHH)신호전도통로적주요성원,재SHH통신과정리발휘교량작용.재다충종류조직중균가이검측도SHH적이상표체,이선암간세포SHH신호적표체명현고우보통이선암세포.SHH신호여종류간세포적자아복제,종류혈관화기질형성밀절상관.사용이배파알、GDC-0449등SMO길항제가이억제SHH신호적이상전도,유효조지종류적생장화전이.목전이유다충SMO길항제작위항종류약물진입Ⅰ기혹Ⅱ기림상시험,이경유이SMO길항제치료이선암적Ⅰ기림상시험.작위경전적SMO길항제,배파알시종전통약용식물중제취출래적생물감,저가능위중의약연구자제공사로,종중약중연발경가유효적SMO길항제.
Smoothened (SMO) is a member of sonic hedgehog homology (SHH) signaling pathway.It plays a key role as a bridge between patched-1 (PTCH-1) and Gli.Aberrant SHH expression can be detected in various malignant tissues,and the expression in pancreatic cancer stem cells is higher apparently.SHH signals are closely associated with self-duplication of cancer stem cells,formation of tumor vessels as well as matrixes.SMO antagonists such as cyclopamine,GDC-0449 and so on show potential to inhibit activity of SHH signaling,and arrest the growth as well as metastases of tumors.Recently,a few of SMO antagonists have been studied in phase Ⅰ clinical trials and some are in phase Ⅱ,meanwhile,phase Ⅰ or Ⅱ trials of SMO antagonists to treat pancreatic cancer are performed currently.As the classical SMO antagonist,cyclopamine is extracted from a medicinal plant.Perhaps researchers may be able to determine more effective SMO-targeting drugs from herbal medicines in the future.